Scientists pinpoint protein that helps cancer-causing viruses evade immune response

Feb. 8, 2023
A study in Nature Communications shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus hijack a human protein to help the viruses evade innate immune detection to spread undeterred.

The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers. UNC School of Medicine scientists have discovered that these viruses use a human protein called barrier-to-autointegration factor 1, or BAF, to evade our innate immune response, allowing the viruses to spread and cause disease.

These findings, published in Nature Communications, suggest that BAF and related proteins could be therapeutic targets to prevent these viruses from spreading and leading to cancers, such as Kaposi sarcoma, non-Hodgkin lymphoma, Hodgkin lymphoma, multicentric Castleman disease, nasopharyngeal carcinoma, and gastric cancer.

In the case of KSHV and EBV, the expression of BAF is increased upon infection, suggesting that these viruses take advantage of this host protein to blunt the immune response to infection. In a series of experiments, the lab found that BAF contributes to the degradation of the cGAS DNA sensor. With less cGAS protein available in the infected cell to detect DNA, the cells mount weaker immune responses, which allows these two viruses to replicate and spread more efficiently.

UNC release

ID 165795609 © Blackboard373 | Dreamstime.com
dreamstime_xxl_165795609
ID 174899697 © Blackboard373 | Dreamstime.com
dreamstime_xxl_174899697
By Kenny on Adobe Stock
adobestock_1155586401
By Nina L/peopleimages.com on Adobe Stock
adobestock_571250691